Altimmune Inc
F:3G0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Altimmune Inc
F:3G0
|
US |
Intrinsic Value
The intrinsic value of 
Altimmune Inc (3G0) under the Base Case is 2.266 EUR per share.
Compared with the current market price of 1.906 EUR, the stock appears
Undervalued by 16% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Altimmune Does
Altimmune is a clinical-stage biotechnology company that develops drugs for obesity, liver disease, and other serious conditions. It does not sell a finished medicine today; instead, it designs and tests experimental treatments in clinical trials, with a focus on peptide-based drugs and vaccine candidates.
- Headquarters
- United States of America US
- Employees
- 57
- IPO date
- Oct 6, 2005
Revenue & Expenses Breakdown
Altimmune Inc
Earnings Waterfall
Altimmune Inc
The intrinsic value for Altimmune Inc (3G0) under the Base Case is 2.266 EUR.
Compared with the current market price of 1.906 EUR, the stock appears Undervalued by 16% .